Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis — Davide Mauri (2006) | RDL Network
Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis
Article 2006 en
Authors
DM
Davide Mauri
NP
Nicholas Pavlidis
NP
Nikolaos P. Polyzos
Abstract
1 min read
Inhibition of the aromatase system, in particular with third-generation aromatase inhibitors and inactivators, appears to be associated with statistically significant improved survival of patients with advanced breast cancer compared with standard hormonal treatments.
Discussion(0)
No comments yet. Be the first to comment.